LNZA · Lanzatech Global, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.02M | - | $9.28M | $9.08M | $9.48M | - | $9.94M | $17.38M | $10.24M | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | $4.01M | - | $10.26M | $14.94M | $16.49M | - | $22.01M | $21.48M | $17.06M | - |
| SG&A | $8.59M | - | $6.74M | $19.11M | $15.75M | - | $11.45M | $11.75M | $11.04M | - |
| Total Operating Expenses | $21.83M | - | $24.94M | $41.33M | $40.54M | - | $42.90M | $40.18M | $36.40M | - |
| D&A | $939.0K | - | $1.02M | $1.05M | $781.0K | - | $1.30M | $1.46M | $1.53M | - |
| Operating Income | ($9.81M) | - | ($15.66M) | ($32.24M) | ($31.05M) | - | ($32.96M) | ($22.80M) | ($26.15M) | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $0 | - | $0 | $0 | $0 | - | - | $0 | $0 | - |
| Net Income | ($14.68M) | - | $2.86M | ($32.50M) | ($19.23M) | - | ($57.43M) | ($27.80M) | ($25.51M) | - |
| EPS - Basic | ($1.77) | - | $1.14 | ($0.15) | ($10.00) | - | ($29.00) | ($14.00) | ($13.00) | - |
| EPS - Diluted | ($1.77) | - | $0.99 | ($0.15) | ($10.00) | - | ($29.00) | ($14.00) | ($13.00) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19.86M | $13.16M | $19.63M | $37.37M | $13.78M | $43.50M | $58.74M | $62.19M | $56.75M | $75.58M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | $684.0K | - | - | - | $2.16M | - | - | - | $1.75M |
| Accounts Payable | $10.44M | $10.87M | $6.20M | $3.94M | $6.43M | $5.29M | $3.12M | $4.01M | $2.07M | $4.06M |
| Current Assets | $47.96M | $39.69M | $50.63M | $66.15M | $57.67M | $99.33M | $136.61M | $125.00M | $146.90M | $172.70M |
| Total Assets | $105.21M | $100.21M | $99.29M | $116.30M | $125.83M | $174.68M | $216.22M | $211.88M | $214.50M | $241.62M |
| Current Liabilities | $24.41M | $27.72M | $24.84M | $55.82M | $26.52M | $30.45M | $46.92M | $28.39M | $21.32M | $27.78M |
| Long-term Debt | - | - | - | - | - | - | - | $9.25M | $15.47M | $25.15M |
| Total Liabilities | $57.15M | $90.93M | $91.10M | $128.31M | $127.01M | $161.24M | $202.61M | $144.34M | $122.68M | $127.15M |
| Stockholders' Equity | $48.06M | ($3.89M) | ($4.98M) | ($25.18M) | ($1.17M) | $13.45M | $13.61M | $67.54M | $91.82M | $114.47M |
| Retained Earnings | ($1.03B) | ($1.02B) | ($1.02B) | ($1.02B) | ($988.83M) | ($969.60M) | ($942.61M) | ($885.18M) | ($857.38M) | ($831.87M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($9.27M) | - | - | - | ($21.10M) | - | - | - | ($28.29M) | - |
| Investing Cash Flow | ($2.01M) | - | - | - | $4.29M | - | - | - | $9.22M | - |
| Financing Cash Flow | $18.00M | - | - | - | ($12.50M) | - | - | - | $186.0K | - |
| CapEx | $55.0K | - | - | - | $713.0K | - | - | - | $1.48M | - |
| Free Cash Flow | ($9.32M) | - | - | - | ($21.81M) | - | - | - | ($29.77M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | -81.6% | - | -168.7% | -354.9% | -327.5% | - | -331.5% | -131.2% | -255.3% | - |
| EBITDA margin | -73.8% | - | -157.7% | -343.3% | -319.2% | - | -318.4% | -122.8% | -240.4% | - |
| Net margin | -122.1% | - | 30.8% | -357.8% | -202.8% | - | -577.6% | -160.0% | -249.0% | - |
| Free cash flow margin | -77.6% | - | - | - | -230.0% | - | - | - | -290.6% | - |
| FCF / Net income | 0.64 | - | - | - | 1.13 | - | - | - | 1.17 | - |
| R&D / Revenue | 33.3% | - | 110.5% | 164.4% | 173.9% | - | 221.3% | 123.6% | 166.5% | - |
| SG&A / Revenue | 71.5% | - | 72.6% | 210.3% | 166.1% | - | 115.2% | 67.6% | 107.7% | - |
| Effective tax rate | - | - | 0.0% | - | - | - | - | - | - | - |
| Return on assets | -14.0% | - | 2.9% | -27.9% | -15.3% | - | -26.6% | -13.1% | -11.9% | - |
| Return on equity | -30.5% | - | -57.5% | 129.0% | 1637.9% | - | -422.1% | -41.2% | -27.8% | - |
| Return on invested capital | - | - | - | - | - | - | - | -23.5% | -19.3% | - |
| Liquidity | ||||||||||
| Current ratio | 1.96 | 1.43 | 2.04 | 1.19 | 2.17 | 3.26 | 2.91 | 4.40 | 6.89 | 6.22 |
| Quick ratio | 1.96 | 1.41 | 2.04 | 1.19 | 2.17 | 3.19 | 2.91 | 4.40 | 6.89 | 6.15 |
| Cash ratio | 0.81 | 0.47 | 0.79 | 0.67 | 0.52 | 1.43 | 1.25 | 2.19 | 2.66 | 2.72 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | 0.14 | 0.17 | 0.22 |
| Debt / Assets | - | - | - | - | - | - | - | 0.04 | 0.07 | 0.10 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 2.19 | -25.75 | -19.95 | -4.62 | -107.18 | 12.99 | 15.89 | 3.14 | 2.34 | 2.11 |
| Liabilities / Assets | 0.54 | 0.91 | 0.92 | 1.10 | 1.01 | 0.92 | 0.94 | 0.68 | 0.57 | 0.53 |
| Efficiency | ||||||||||
| Asset turnover | 0.11 | - | 0.09 | 0.08 | 0.08 | - | 0.05 | 0.08 | 0.05 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | 24.8x | - | - | - | - | - | - | - |
| P / B | 2.8x | - | - | - | - | - | 2776.5x | 541.7x | 664.0x | - |
| P / S | 11.0x | - | 7.0x | 650.7x | 501.5x | - | 3799.1x | 2105.5x | 5951.2x | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 26.8% | - | -6.7% | -47.7% | -7.4% | - | -49.3% | 34.5% | 30.4% | - |
| Revenue CAGR (3y) | 15.2% | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 68.4% | - | 52.5% | -41.4% | -18.7% | - | -34.0% | 25.5% | 19.6% | - |
| Net income growth (YoY) | 23.7% | - | - | -16.9% | 24.6% | - | -126.8% | -3.8% | 59.7% | - |
| EPS growth (YoY) | 82.3% | - | - | 98.9% | 23.1% | - | -22207.7% | -9900.0% | -356.1% | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | 57.3% | - | - | - | 26.7% | - | - | - | 16.6% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | - | - | - | - | - | -88.3% | -89.4% | -68.1% | -60.0% | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$55.84M totalReportable Segment$55.84M · 100.0%
Product / service
$156.25M totalBiorefining$36.03M · 23.1%
Service$20.50M · 13.1%
License And Service$19.84M · 12.7%
Service And Grants$18.30M · 11.7%
Engineering And Other Services$16.19M · 10.4%
Carbon Smart$14.63M · 9.4%
Tangible Products$14.63M · 9.4%
Grant Contributions Engineering And Other Services$5.77M · 3.7%
Research And Development$5.19M · 3.3%
Other Contract Research$2.77M · 1.8%
Joint Development Agreements$2.42M · 1.6%
Geographic
$55.84M totalNorth America$24.68M · 44.2%
Asia$16.52M · 29.6%
Europe$14.64M · 26.2%
Peer comparison
Same SIC group: Industrial Organic Chemicals
Comparing LanzaTech Global against the 5 most active filers in the same SIC group.